Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenues [Abstract]    
Net sales $ 626,631 $ 0
Grant revenue 125,173 0
Total revenue 751,804 0
Cost of goods sold 193,220 0
Gross profit 558,584 0
Operating expenses:    
Research and development 5,226,794 3,639,757
Selling, general and administrative 3,910,833 3,364,490
Total operating expenses 9,137,627 7,004,247
Loss from operations (8,579,043) (7,004,247)
Other income (expense):    
Interest income 6,793 1,497
Interest expense (943,838) (363,082)
Loss on extinguishment of debt (2,610,196) 0
Change in fair value of financial instruments 392,483 0
Other, net (6,752) 24,813
Total other expense, net (3,161,510) (336,772)
Net loss attributable to common stockholders $ (11,740,553) $ (7,341,019)
Loss per common share (basic and diluted) $ (0.08) $ (0.06)
Weighted average shares outstanding (basic and diluted) 144,783,351 113,763,600